2016
Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Million Persons Project pilot
Lu J, Xuan S, Downing NS, Wu C, Li L, Krumholz HM, Jiang L. Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) Million Persons Project pilot. BMJ Open 2016, 6: e010200. PMID: 26729395, PMCID: PMC4716208, DOI: 10.1136/bmjopen-2015-010200.Peer-Reviewed Original ResearchConceptsHigh-risk subjectsCardiovascular diseaseBlood pressureMedical historyFurther health assessmentsLipid blood testsMillion Persons ProjectPotential lifestyle changesReturn clinic visitsPopulation-based assessmentCommunity-dwelling residentsHealth-related behaviorsCollection of bloodBaseline characteristicsClinic visitsBlood testsLeading causeSurvival statusLifestyle changesHigh riskUrine analysisHealth statusAnthropometric variablesTelephone interviewsCentral Ethics Committee
1999
Risk factors for cardiovascular disease: one down, many more to evaluate.
Vaccarino V, Krumholz H. Risk factors for cardiovascular disease: one down, many more to evaluate. Annals Of Internal Medicine 1999, 131: 62-3. PMID: 10391817, DOI: 10.7326/0003-4819-131-1-199907060-00012.Peer-Reviewed Original ResearchBiomarkersCardiovascular DiseasesDisease ProgressionEpidemiologic MethodsHumansRisk FactorsUric Acid
1996
Epidemiologic and economic impact of advanced heart failure
Funk M, Krumholz H. Epidemiologic and economic impact of advanced heart failure. The Journal Of Cardiovascular Nursing 1996, 10: 1-10. PMID: 8656234, DOI: 10.1097/00005082-199601000-00002.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overCost of IllnessEpidemiologic MethodsFemaleHeart FailureHumansIncidenceMaleMiddle AgedPrevalencePrognosisRisk FactorsUnited StatesConceptsHeart failureMajor public health problemAdvanced heart failureCoronary heart diseasePublic health problemFinal common pathwayHeart diseaseRisk factorsCardiovascular diseaseCardiovascular conditionsHealth problemsPremature deathLethal conditionCommon pathwayPrevalenceDiseaseIncidenceNumber of peopleFailureEconomic impactPrognosisMortality